Myrcene is a plant-produced terpene that reduces pain, fights inflammation, and promotes sleep. It’s the most abundant terpene in both hops and cannabis, and it shows up in meaningful concentrations in lemongrass, mangoes, and bay leaves. While most research so far comes from animal studies, the findings consistently point to real biological activity, not just pleasant aromatics.
Where Myrcene Comes From
Myrcene belongs to the monoterpene family, a class of lightweight aromatic compounds that plants produce naturally. In its pure form, it’s a yellow, oily liquid with a sweet, earthy scent. Hop essential oil contains the highest concentrations of any plant source, with myrcene making up as much as 70% of the oil by volume. That’s why hoppy beers have that characteristic herbal, slightly musky quality.
Lemongrass essential oil contains 15 to 20% myrcene, which partly explains its long history in folk medicine for pain relief. Cannabis is the other major source. Strains with more than 0.5% myrcene by dry weight tend to produce noticeably more sedating effects than strains with less. If you’ve ever heard someone describe a cannabis strain as having a “couch-lock” quality, high myrcene content is a likely contributor.
Pain Relief and Anti-Inflammatory Effects
Myrcene’s best-studied property is its ability to reduce pain. In animal models of arthritis, applying myrcene directly to inflamed joints produced dose-dependent pain relief over a three-hour window. At the peak effect (around two hours), even the lower dose improved pain sensitivity by roughly 211%, while the higher dose reached 269%. Those are substantial shifts in measurable pain thresholds, not subtle effects.
The inflammation side is equally interesting. In arthritic joints, myrcene reduced the rolling and sticking of white blood cells along blood vessel walls, a direct marker of active inflammation. In human cartilage cells from arthritic joints, myrcene lowered the activity of an enzyme that drives inflammation and interrupted a key inflammatory signaling chain triggered by a protein called interleukin-1β. Notably, these anti-inflammatory effects were local rather than systemic. Blood tests in chronically treated animals showed no change in circulating inflammatory markers, suggesting myrcene works at the tissue level rather than suppressing the whole immune system.
The pain-relieving mechanism appears to involve the body’s own opioid system. When injected in animal models, myrcene increased pain tolerance in heat-based pain tests, and this effect depended on the release of the body’s natural painkillers. Lemongrass oil (rich in myrcene) has produced analgesic effects comparable to peripheral-acting opioid drugs in multiple experimental pain models. Repeated oral dosing also avoided tolerance buildup, meaning the effect didn’t weaken with continued use in those studies.
Sleep and Sedation
Myrcene promotes sleep through a specific brain signaling pathway involving serotonin. In mice with chemically induced insomnia, myrcene increased levels of two key calming neurotransmitters: serotonin and GABA. At the same time, it decreased levels of glutamate, an excitatory brain chemical that keeps you alert. The ratio of GABA to glutamate shifted toward relaxation, both in the bloodstream and in the hypothalamus, the brain region that regulates your sleep-wake cycle.
The mechanism works like a chain reaction. Serotonin binds to receptors on brain cells, which triggers production of a secondary messenger molecule called cAMP inside the cell. That messenger activates a protein that ultimately boosts GABA levels further. So myrcene doesn’t just nudge one neurotransmitter; it tips a whole signaling cascade toward sleep. These effects held up both after a single dose and after seven consecutive days of treatment, with the compound also protecting hypothalamic neurons from damage caused by the insomnia-inducing chemical.
How Myrcene Interacts With the Cannabinoid System
One of the more nuanced findings about myrcene is how it interacts with the body’s endocannabinoid system. In mouse models of nerve pain, myrcene reduced pain sensitivity in a dose-dependent way, and this effect was completely blocked by a cannabinoid receptor antagonist (a drug that prevents the receptor from activating). That initially suggested myrcene was directly stimulating cannabinoid receptors the way THC does.
But lab tests on isolated cells told a different story. Myrcene does not directly activate cannabinoid receptors, and it doesn’t change how THC or the body’s own cannabinoids bind to those receptors. The most likely explanation is that myrcene increases the availability of endocannabinoids, the body’s own cannabis-like molecules, called anandamide and 2-AG. These then activate the receptors naturally. This indirect mechanism may explain why myrcene didn’t produce other classic cannabinoid effects like reduced body temperature or slowed movement, which direct receptor activation typically causes.
One important detail: female mice were more sensitive to myrcene’s pain-relieving effects than males, consistent with sex differences seen with THC. And while myrcene reduced pain effectively, animals showed an aversion to it in preference testing, similar to how higher doses of THC can feel unpleasant. That’s a flag for anyone assuming more is automatically better.
Neuroprotective and Antioxidant Properties
In a rodent model designed to mimic the dopamine-producing neuron loss seen in Parkinson’s disease, myrcene treatment preserved those neurons through several overlapping mechanisms. It restored the brain’s natural antioxidant defenses, reduced markers of oxidative damage to cell membranes, and dialed down activation of the brain’s immune cells (microglia and astrocytes), which can cause collateral damage when they stay in overdrive.
Myrcene also helped normalize the cell’s internal recycling system, called autophagy. In the disease model, this recycling process goes haywire, leading to a buildup of misfolded proteins. Myrcene restored proper recycling activity and reduced accumulation of alpha-synuclein, the protein that clumps together in Parkinson’s disease. These results are from a single animal study using a 50 mg/kg dose, so they’re far from clinical proof, but they outline a plausible set of protective pathways.
The Entourage Effect in Cannabis
Myrcene is central to the “entourage effect” theory, which holds that terpenes and cannabinoids work better together than any single compound works alone. Cannabis strains with myrcene concentrations above 0.5% are associated with stronger sedative effects, regardless of their THC content. This is consistent with myrcene’s independent activity on serotonin, GABA, and endocannabinoid pathways, all of which overlap with THC’s own mechanisms.
The practical implication: if you’re choosing cannabis products and care about the type of effect, the terpene profile matters, not just the THC percentage. A high-myrcene strain will likely feel more physically relaxing and sleep-inducing than a strain with the same THC level but a different dominant terpene. Many dispensaries now list terpene content on labels for this reason.
Practical Details
Myrcene’s boiling point sits around 332°F (167°C), which is lower than most cannabinoids. If you’re vaporizing cannabis, this means myrcene is released early in the heating process. At higher temperatures, you may lose it before other compounds fully activate. For essential oil use, lemongrass oil is the most accessible high-myrcene source and has the longest track record in traditional pain and relaxation applications.
Most of the biological research on myrcene uses isolated, purified compound in controlled doses. The concentrations in a cup of lemongrass tea or a hoppy beer are far lower than what’s used in these studies. That doesn’t mean dietary exposure is meaningless, but it does mean the dramatic effects seen in lab settings won’t necessarily translate to casual consumption at the same magnitude.